LPL Financial’s Mateon Therapeutics, Inc. MATN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-12,887
Closed -$8K 2849
2016
Q3
$8K Hold
12,887
﹤0.01% 2623
2016
Q2
$9K Buy
+12,887
New +$9.13K ﹤0.01% 2610

Other funds holding MATN

LPL Financial's MATN Position: Q4 2016 in Review

LPL Financial sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 12,887 shares — an estimated $8K sold.

LPL Financial first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $9K in Q2 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

  • LPL Financial reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • LPL Financial sold 12,887 Mateon Therapeutics, Inc. shares in Q4 2016, an estimated $8K.
  • LPL Financial first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
  • LPL Financial's Mateon Therapeutics, Inc. position peaked at $9K in Q2 2016.
  • 1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.

Based on LPL Financial's 13F filing for Q4 2016, filed 13 Feb 2017.